Central venous catheter-related bloodstream infections: Epidemiology and risk factors for hematogenous complications

被引:1
|
作者
Bell, Elisabeth Carolle Ngo [1 ]
Chapon, Virginie [2 ]
Bessede, Emilie [3 ]
Meriglier, Etienne [4 ]
Issa, Nahema [5 ]
Domblides, Charlotte [6 ]
Bonnet, Fabrice [2 ,7 ]
Vandenhende, Marie-Anne [4 ,8 ,9 ]
机构
[1] Ctr Hosp Angouleme, Serv Med Interne, F-16000 Angouleme, France
[2] Univ Bordeaux, CHU Bordeaux, Serv Med Interne & Malad Infect, F-33000 Bordeaux, France
[3] Hop Pellegrin, CHU Bordeaux, Lab Bacteriol, F-33000 Bordeaux, France
[4] Hop Pellegrin, Inst Bergonie, CHU Bordeaux, INSERM,Serv Med Interne,CIC EC 1401, F-33000 Bordeaux, France
[5] Hop St Andre, CHU Bordeaux, Serv Reanimat Med, F-33000 Bordeaux, France
[6] CHU Bordeaux, Ctr Hospitalier Univ Bordeaux, Serv Oncol Med, F-33000 Bordeaux, France
[7] Univ Bordeaux, INSERM, BPH, U1219, F-33000 Bordeaux, France
[8] Univ Bordeaux, Inst Bergonie, INSERM, CIC EC 1401, F-33000 Bordeaux, France
[9] Hop Pellegrin, CHU Bordeaux, Serv Med Interne, F-33000 Bordeaux, France
来源
INFECTIOUS DISEASES NOW | 2024年 / 54卷 / 03期
关键词
Catheter; Bloodstream infection; Death; Endocarditis; Hematogenous complication; STAPHYLOCOCCUS-AUREUS BACTEREMIA; CANCER-PATIENTS; MORTALITY; COSTS; MANAGEMENT; DIAGNOSIS;
D O I
10.1016/j.idnow.2024.104859
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Central catheter-related bloodstream infections (CRBIs) can lead to severe complications, including suppurative thrombophlebitis, endocarditis, and metastatic infections. While complications due to CRBIs caused by Staphylococcus aureus (SA) are well-known, there are limited data regarding CRBIs caused by other bacteria. Methods: This 2-year retrospective single-center study of patients with CRBIs from a tertiary care hospital examined the hematogenous complications associated with CRBIs according to patient characteristics, central venous catheter (CVC) types, and causative bacteria. Results: All in all, 254 patients with confirmed CRBIs were included; 285 bacteria types were isolated, mainly Enterobacteriaceae (n = 94), coagulase-negative Staphylococci (CNS, n = 82), SA (n = 45), and non-fermenting Gram-negative bacteria (NGB, n = 45). Among the patients, 35 developed at least one hematogenous complication (14 %), including suppurative thrombophlebitis (n = 15), endocarditis (n = 7) and metastatic infections (n = 16). In multivariate analysis, hemodialysis, persistent bacteremia for at least 3 days, and CRBIs caused by SA were associated with increased risk for hematogenous complications, while previous curative anticoagulant treatment was associated with reduced risk. Diabetes, CVC maintenance, and hematogenous complications were associated with increased 3-month mortality. Conclusion: A thorough investigation of hematogenous complications should be envisioned in patients with persistent bacteremia, particularly those with SA infections and those on hemodialysis.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Detection of central venous catheter-related bloodstream infections in haematooncological patients
    Rabensteiner, Jasmin
    Theiler, Georg
    Duettmann, Wiebke
    Zollner-Schwetz, Ines
    Hoenigl, Martin
    Valentin, Thomas
    Leitner, Eva
    Luxner, Josefa
    Grisold, Andrea
    Valentin, Angelika
    Neumeister, Peter
    Krause, Robert
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2015, 45 (08) : 824 - 832
  • [2] Risk factors for recurrent catheter-related infections after catheter-related bloodstream infections
    Chin, Bum Sik
    Han, Sang Hoon
    Lee, Han Sung
    Jeong, Su Jin
    Choi, Heekyoung
    Kim, Chang Oh
    Choi, Jun Yong
    Song, Young Goo
    Kim, June Myung
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 (01) : E16 - E21
  • [3] Central venous catheter-related bloodstream infections: an analysis of incidence and risk factors in a cohort of 400 patients
    Gowardman, JR
    Montgomery, C
    Thirlwell, S
    Shewan, S
    Idema, A
    Larsen, PD
    Havill, JH
    INTENSIVE CARE MEDICINE, 1998, 24 (10) : 1034 - 1039
  • [4] Central venous catheter-related bloodstream infections: an analysis of incidence and risk factors in a cohort of 400 patients
    J. R. Gowardman
    C. Montgomery
    S. Thirlwell
    J. Shewan
    A. Idema
    P. D. Larsen
    J. H. Havill
    Intensive Care Medicine, 1998, 24 : 1034 - 1039
  • [5] Clinical impact of early reinsertion of a central venous catheter after catheter removal in patients with catheter-related bloodstream infections
    Lee, Yu-Mi
    Ryu, Byung-Han
    Hong, Sun In
    Cho, Oh-Hyun
    Hong, Kyung-Wook
    Bae, In-Gyu
    Kwack, Won Gun
    Kim, Young Jin
    Chung, Eun Kyoung
    Kim, Dong Youn
    Lee, Mi Suk
    Park, Ki-Ho
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2021, 42 (02) : 162 - 168
  • [6] Risk factors for central venous catheter-related infections in a neonatal population - systematic review
    Rosado, Viviane
    Camargos, Paulo A. M.
    Anchieta, Leni M.
    Bouzada, Maria C. F.
    de Oliveira, Gabriela M.
    Clemente, Wanessa T.
    Romanelli, Roberta M. de C.
    JORNAL DE PEDIATRIA, 2018, 94 (01) : 3 - 14
  • [7] Changing Epidemiology of Catheter-Related Bloodstream Infections in Cancer Patients
    Chaftari, Anne Marie
    Hachem, Ray
    Jiang, Ying
    Shah, Pankil
    Hussain, Alawami
    Al Hamal, Zainab
    Yousif, Ammar
    Jordan, Mary
    Michael, Majd
    Raad, Issam
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2018, 39 (06) : 727 - 729
  • [8] Catheter-related Bloodstream Infections
    Antonio Sitges-Serra
    Meritxell Girvent
    World Journal of Surgery, 1999, 23 : 589 - 595
  • [9] Management and Prevention of Central Venous Catheter-Related Infections in the ICU
    Buetti, Niccolo
    Timsit, Jean-Francois
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 40 (04) : 508 - 523
  • [10] Sex-Disaggregated Analysis of Central Venous Catheter-Related Bloodstream Infections in Patients with Cancer
    Schalk, Enrico
    Seltmann, Alva
    Boell, Boris
    Giesen, Nicola
    Grans-Siebel, Judit
    Kriege, Oliver
    Lanznaster, Julia
    Minti, Antrea
    Naendrup, Jan-Hendrik
    Neitz, Julia
    Panse, Jens
    Schmidt-Hieber, Martin
    Seggewiss-Bernhardt, Ruth
    Teschner, Daniel
    Weber, Philipp
    Wille, Kai
    von Lilienfeld-Toal, Marie
    Hentrich, Marcus
    ONCOLOGY RESEARCH AND TREATMENT, 2024, : 37 - 46